Skip to main content

Table 4 Correlation for BCVA gain after three conbercept treatment and mean sensitivity changes from different regions

From: Correlation of retinal layer changes with vision gain in diabetic macular edema during conbercept treatment

Region

Baseline (db)

3 months(db)

Changes (db)

Correlation Coefficient r

p

Average

8.17 ± 3.66

9.51 ± 4.18

1.33 ± 2.00

0.433

0.056

Central

4.60 ± 2.95

5.87 ± 3.68

1.27 ± 2.35

0.531

0.016

I.S.

8.59 ± 3.92

9.86 ± 4.34

1.28 ± 1.93

0.014

0.954

I.I.

8.79 ± 4.54

10.56 ± 4.81

1.78 ± 2.66

0.409

0.073

I.N.

9.80 ± 4.92

11.15 ± 4.76

1.35 ± 2.71

0.444

0.05

I.T.

9.09 ± 4.19

10.09 ± 4.85

1.00 ± 2.27

0.338

0.144

  1. Significant p values are in bold
  2. Region: Standard EDTRS grid are used with central subfield (r = 0.5 mm) (Central), inner ring(r = 0.5–1.5 mm) (I), Inner ring and outer ring are divided into four parts: superior part (S), inferior part (I), nasal part (N) and temporal part (T). I.S. stand for superior part of inner ring and so are the others
  3. Dependent variable: BCVA Best-corrected vision acuity gain at the 3 months Visit
  4. Explanatory variables: changes of mean sensitivity in 3 months
Back to article page

BMC Ophthalmology

ISSN: 1471-2415

Contact us